| 701 | 29867591 | Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone. | Front Physiol | 2018 |
1 |
| 702 | 29873514 | Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice. | Am J Physiol Renal Physiol | 2018 Sep 1 |
6 |
| 703 | 29936386 | Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. | Colloids Surf B Biointerfaces | 2018 Oct 1 |
1 |
| 704 | 30099761 | Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy. | Clin Exp Pharmacol Physiol | 2019 Mar |
4 |
| 705 | 30223427 | The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension. | Molecules | 2018 Sep 14 |
2 |
| 706 | 30325243 | TRPV4 activation in rat carotid artery in DOCA hypertension involves eNOS and endothelium-derived contractile factor (EDCF). | Clin Exp Hypertens | 2019 |
4 |
| 707 | 30354753 | Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension. | Hypertension | 2018 Sep |
8 |
| 708 | 30357309 | Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. | Cardiovasc Res | 2019 Mar 15 |
1 |
| 709 | 30628826 | IGF-1 deletion affects renal sympathetic nerve activity, left ventricular dysfunction, and renal function in DOCA-salt hypertensive mice. | Physiol Res | 2019 Apr 30 |
2 |
| 710 | 30636551 | B-Cell Deficiency Lowers Blood Pressure in Mice. | Hypertension | 2019 Mar |
1 |
| 711 | 30782301 | Upregulation of Tumor Susceptibility Gene 101 (TSG101) by mechanical stress in podocytes. | Cell Mol Biol (Noisy-le-grand) | 2019 Jan 31 |
1 |
| 712 | 30894089 | Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling. | Circ Res | 2019 May 10 |
3 |
| 713 | 30925093 | (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT<sub>1</sub> receptor-mediated calcium events. | Am J Physiol Heart Circ Physiol | 2019 Jun 1 |
1 |
| 714 | 31006330 | Activation of ADAM17 (A Disintegrin and Metalloprotease 17) on Glutamatergic Neurons Selectively Promotes Sympathoexcitation. | Hypertension | 2019 Jun |
2 |
| 715 | 31067198 | NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension. | Hypertension | 2019 Jun |
1 |
| 716 | 31151511 | Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer. | Carbohydr Polym | 2019 Sep 1 |
2 |
| 717 | 31223486 | Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice. | Clin Hypertens | 2019 |
4 |
| 718 | 31274353 | Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension. | Am J Physiol Heart Circ Physiol | 2019 Sep 1 |
2 |
| 719 | 31599781 | DOCA/Salt: Much More Than a Model of Hypertension. | J Cardiovasc Pharmacol | 2019 Nov |
2 |
| 720 | 31615657 | Overexpression of myeloid angiotensin-converting enzyme (ACE) reduces atherosclerosis. | Biochem Biophys Res Commun | 2019 Dec 10 |
1 |
| 721 | 31629736 | Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice. | J Mol Cell Cardiol | 2019 Dec |
1 |
| 722 | 31704980 | Evidence of Cardiovascular Calcification and Fibrosis in Pseudoxanthoma Elasticum Mouse Models Subjected to DOCA-Salt Hypertension. | Sci Rep | 2019 Nov 8 |
1 |
| 723 | 31871958 | Adipose Mesenchymal Cells-Derived EVs Alleviate DOCA-Salt-Induced Hypertension by Promoting Cardio-Renal Protection. | Mol Ther Methods Clin Dev | 2020 Mar 13 |
2 |
| 724 | 31924817 | Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension. | Sci Rep | 2020 Jan 10 |
7 |
| 725 | 32087969 | Adenosine A<sub>2A</sub> receptor activation prevents DOCA-salt induced hypertensive cardiac remodeling via iBAT. | Biochem Biophys Res Commun | 2020 Feb 19 |
3 |
| 726 | 32141572 | Effect of imatinib on DOCA-induced myocardial fibrosis in rats through P38 MAPK signaling pathway. | Eur Rev Med Pharmacol Sci | 2020 Feb |
11 |
| 727 | 32190663 | Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice. | Biomed Res Int | 2020 |
8 |
| 728 | 32393187 | Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice. | BMC Nephrol | 2020 May 11 |
1 |
| 729 | 32799674 | COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats. | Am J Physiol Renal Physiol | 2020 Oct 1 |
5 |
| 730 | 32829380 | ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway. | Cell Death Dis | 2020 Aug 22 |
7 |
| 731 | 32908237 | Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway. | Hypertens Res | 2021 Feb |
3 |
| 732 | 32939821 | Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate-salt hypertensive uni-nephrectomized KKA<sup>y</sup> mice. | FASEB J | 2020 Nov |
4 |
| 733 | 32960965 | Oestrogen inhibits salt-dependent hypertension by suppressing GABAergic excitation in magnocellular AVP neurons. | Cardiovasc Res | 2021 Aug 29 |
2 |
| 734 | 33097689 | Correction: ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway. | Cell Death Dis | 2020 Oct 23 |
1 |
| 735 | 33249862 | β-Arrestin-Biased Agonist Targeting the Brain AT<sub>1</sub>R (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension. | Hypertension | 2021 Feb |
2 |
| 736 | 33432452 | P-Selectin Glycoprotein Ligand-1 Deficiency Protects Against Aortic Aneurysm Formation Induced by DOCA Plus Salt. | Cardiovasc Drugs Ther | 2022 Feb |
2 |
| 737 | 33464650 | LncRNA SNHG12 alleviates hypertensive vascular endothelial injury through miR-25-3p/SIRT6 pathway. | J Leukoc Biol | 2021 Oct |
1 |
| 738 | 33534341 | Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice. | J Hypertens | 2021 Aug 1 |
1 |
| 739 | 33633591 | Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin. | Front Physiol | 2021 |
8 |
| 740 | 33879002 | Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension. | Clin Exp Hypertens | 2021 Aug 18 |
2 |
| 741 | 34156149 | Super-resolved local recruitment of CLDN5 to filtration slits implicates a direct relationship with podocyte foot process effacement. | J Cell Mol Med | 2021 Aug |
1 |
| 742 | 34275335 | Novel Role of GPR35 (G-Protein-Coupled Receptor 35) in the Regulation of Endothelial Cell Function and Blood Pressure. | Hypertension | 2021 Sep |
1 |
| 743 | 34488433 | IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice. | Hypertension | 2021 Nov |
5 |
| 744 | 34773993 | Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism. | Mol Med | 2021 Nov 13 |
2 |
| 745 | 34840266 | Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt-Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats. | J Cardiovasc Pharmacol | 2022 Mar 1 |
5 |
| 746 | 34871556 | Secreted protein acidic and rich in cysteine (SPARC) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) increments by the renin-angiotensin system induce renal fibrosis in deoxycorticosterone acetate-salt hypertensive rats. | Eur J Pharmacol | 2022 Jan 5 |
3 |
| 747 | 34916661 | Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension. | Hypertens Res | 2022 Feb |
1 |
| 748 | 35075545 | Zyxin protects from hypertension-induced cardiac dysfunction. | Cell Mol Life Sci | 2022 Jan 24 |
2 |
| 749 | 35348007 | Cardiometabolic effects of DOCA-salt in male C57BL/6J mice are variably dependent on sodium and nonsodium components of diet. | Am J Physiol Regul Integr Comp Physiol | 2022 Jun 1 |
2 |